from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2527/vapC17

LFCtreatmentdescriptionclass of inhibitor

-0.522

Amikacinug/mL Amikacintranslation

-0.328

Cap5-10ug/mL Capreomycintranslation

-0.668

Rox10-50 ug/mL Roxithromycintranslation

0.698

SM2-5 ug/mL Streptomycintranslation

-0.466

Tet5-10 ug/mL Tetracyclinetranslation

-1.118

Rif0.2-5ug/mL Rifampicintranscription

-0.814

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.766

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.169

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.050

CPZ10-50 ug/mL Chlorpromazinerespiration

0.448

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.226

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.918

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.912

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.033

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.272

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.473

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.520

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.162

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.476

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.143

KCN5-20 ug/mL Potassium cyaniderespiration

0.864

NaN30.2-2 mM Sodium aziderespiration

0.019

Nigericin50 uM Nigericinrespiration

1.747

TRC10-150 ug/mL Triclosanrespiration

0.928

TRZ10-25 ug/mL Thioridazinerespiration

1.460

Valinomycin0.5-10 uM Valinomycinrespiration

-1.173

ZnSO42 mM ZnSO4respiration

0.133

menadione6-10 ug/mL Menadionerespiration

-0.418

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.815

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.392

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.028

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.135

NRP_1Non-replicating persistence stage 1dosRassociated

0.038

Amp0.2mg/mL AmpicillincellWall

0.106

Cephalexin20-100 ug/mL CephalexincellWall

-0.233

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.074

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.161

EMB10-20 ug/mL EthambutolcellWall

0.110

Eta12-40 ug/mL EthionamidecellWall

-0.211

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.049

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.256

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.071

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.658

BZA0.12 mg/mL BenzamidearomaticAmides

0.561

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.040

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.865

H2O24 mM hydrogen peroxideDNAdamaging

-0.312

Levo10 ug/mL LevofloxacinDNAdamaging

-0.838

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.069

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.175

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.590

UVUV-irradiationDNAdamaging

-1.040

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.556

Antimycin12.5-50 ug/mL Antimycin A?

0.068

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.021

PA_110-50 ug/mL Antitubercular compound PA-1?

0.548

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.725

PA8240.2-2 ug/mL PA-824?

0.119

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.623

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.208

Verapamil50 uM Verapamil?

0.110

mercaptoethanol2 mM 2-Mercaptoethanol?

0.024

methoxatin10-20 ug/mL Methoxatin?